Latest news
- Home
- Press Room
- Latest News
Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.
A first! A presentation in French on TED.com!
Oct. 29, 2013
Pr. Mohamed Hijri's excellent presentation at the TEDxUdeM conference held in Montréal on March 11, 2012 caught the attention of the persons responsible for TED conferences in the US. As of today, his presentation on a microscopic mushroom is online in its French original version on TED.com (English subtitles).
Dawn of a new era for children: Introducing Canada’s first integrated clinical genomic centre in pediatrics
Oct. 21, 2013
Montréal, October 21, 2013 – Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. “We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr. Réjean Hébert, Minister of Health and Social Services and Minister responsible for Seniors,” said Messrs. Brunet and LePage at the official launch.
Génome Québec welcomes National Research and Innovation Policy
Oct. 16, 2013
Montréal, October 16, 2013 – Génome Québec welcomes the National Research and Innovation Policy (PNRI) announced by the Québec Government. The policy is a major step forward in the government’s vision and support of research and innovation, since it now places the sector at the centre of its economic strategy.
New Discoveries for Cancer Risk
Oct. 9, 2013
Researchers Worldwide Take Part
in one of History’s Largest Scientific Consortia
Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool – the OncoArray – manufactured by the U.S. genomics firm Illumina, Inc.